KINGDON CAPITAL MANAGEMENT, L.L.C. – Apellis Pharmaceuticals, Inc. Transaction History
KINGDON CAPITAL MANAGEMENT, L.L.C. portfolio value:
$13.66M
portfolio value
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | put | Increase | 0.00% | 200K shares | 13.66M | $68.3 | 200K |
| Q2 2022 | put | Decrease | -100.00% | -150K shares | -7.62M | $45.22 | 0 |
| Q1 2022 | put | Increase | 0.00% | 150K shares | 7.62M | $50.81 | 150K |
| Q4 2021 | put | Decrease | -100.00% | -50K shares | -1.64M | $47.95 | 0 |
| Q4 2021 | share | Decrease | -100.00% | -100K shares | -3.29M | $47.95 | 0 |
| Q3 2021 | share | Increase | 0.00% | 100K shares | 3.29M | $32.96 | 100K |
| Q3 2021 | put | Increase | 0.00% | 50K shares | 1.64M | $32.96 | 50K |